Caxton Associates (New York)’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,551
Closed -$348K 537
2021
Q4
$348K Sell
12,551
-7,978
-39% -$193K 0.04% 371
2021
Q3
$436K Hold
20,529
0.05% 229
2021
Q2
$339K Buy
+20,529
New +$313K 0.04% 273

Other funds holding CCRN

Caxton Associates (New York)'s CCRN Position: Q1 2022 in Review

Caxton Associates (New York) sold out of Cross Country Healthcare (CCRN) in Q1 2022, closing a stake of 12,551 shares — an estimated $348K sold.

Caxton Associates (New York) first reported a position in CCRN in Q2 2021 and held it in 3 quarters. The position peaked at $436K in Q3 2021. 195 funds tracked by Wall St. Rank hold CCRN as of Q1 2022.

  • Caxton Associates (New York) reported no remaining Cross Country Healthcare position as of Q1 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 12,551 Cross Country Healthcare shares in Q1 2022, an estimated $348K.
  • Caxton Associates (New York) first reported a position in Cross Country Healthcare in Q2 2021 and held it in 3 quarters.
  • Caxton Associates (New York)'s Cross Country Healthcare position peaked at $436K in Q3 2021.
  • 195 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2022.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.